Skip to main content
Evidence Based Longevity (EBL)Check what I take
← All protocols
C

Protocol

Low-calorie sweeteners in place of sugar

In randomized trials lasting 4 weeks to 40 months, people given low-calorie sweeteners instead of sugar lost about 1.35 kg more weight, and short trials found lower energy intake.

Grade C: human trials exist, but they are small, mixed or not yet repeated. This is not a finding that it does not work. How to read a grade →

Compare this record with another, side by side →

At a glance

In plain words

Low-calorie sweeteners such as sucralose, aspartame and stevia replace sugar's calories. In trials where people swapped sugar for them, weight came out about 1.4 kg lower. The trials were mostly short and in mixed groups, and none measured diabetes or heart disease.

The letter, taken apart
What was measured
Body weight after 4 weeks to 40 months.
How big
Body weight was 1.35 kg lower with low-calorie sweeteners than with sugar.Read from the summary of PMID PubMed ID: the permanent number the US National Library of Medicine gives a published paper. Each one links to that paper's record on PubMed. 26365102.
Who it applies to
Children and adults in mixed trials. No trial measured diabetes or heart disease.
Safety
None identified in the trials pooled.
The record in one view
Compared with
Sugar-sweetened food or drink.
Certainty
Grade C, resting on: Meta-analysis A study that pools the numbers from several trials into one combined estimate. of randomized trials within a broader systematic review A review that searches for every study on a question using a method set in advance, then assesses them together..
What would change this grade
Could rise to B with: Randomized trial of sweeteners in place of sugar. Who: Adults with obesity. Measured: Body weight at 12 months and type 2 diabetes incidence. Length: At least 12 months.
Cost
No price recorded yet.
Sources
2 studies cited on this record, listed under Sources.
For clinicians
A one-page summary of this record that prints with a clinician's name and practice, folds to a plain-language patient handout, and gives a chart note to paste into the patient record: Printable summary and chart note.
Food
CSurrogate biomarker Grade C

In randomized trials lasting 4 weeks to 40 months, people given low-calorie sweeteners instead of sugar lost about 1.35 kg more weight, and short trials found lower energy intake. Body weight counts toward a B when trials treat obesity for at least 6 months, which these were not, so the letter is C.

Why this letter

Why this gradeGrade C, small or unreplicated trials. The reasoning, and what the grade does not cover.
Why this grade

Grade C on body weight. A meta-analysis of sustained randomized trials found about 1.35 kg less weight when low-energy sweeteners replaced sugar (Rogers et al., 2016; PMID 26365102).

WHY NOT Bunder EBL's body-weight rule, weight qualifies for a B when the trials treat obesity for at least 6 months; these pooled trials ranged from 4 weeks to 40 months in mixed populations and were not obesity treatment trials, and a 2025 meta-analysis of 19 trials found the weight difference held in trials under 18 weeks but not in longer ones (Li et al., 2025; PMID 40913681).

WHAT THIS GRADE DOES NOT COVERdiabetes, cardiovascular events or cancer, which no cited trial measured, and comparisons with water. Comparisons with water are not graded either.

A grade describes the human evidence for a named use. It is not advice, and it is not a judgment on any individual prescription. How the letters are decided →

Who responds: this record's trial reading reports no subgroup that identifies who responds.

Evidence notes: randomized trial, meta-analysis

Endpoint The outcome a trial measures to decide whether the treatment worked, such as heart attacks, blood pressure or a symptom score. graded: Body weight and energy intake (surrogate)

Last reviewed: November 2026

Evidence wanted

The trial that would change this grade.

DesignRandomized trial of sweeteners in place of sugar
PopulationAdults with obesity
EndpointBody weight at 12 months and type 2 diabetes incidence
DurationAt least 12 months

A positive trial of this shape, supported by further trials, would move this entry to B.

Why the current trials fall short

A 6-month or longer obesity treatment trial would let weight count under EBL's rule.

Clinical trials

ClinicalTrials.gov, the public registry run by the U.S. National Library of Medicine, lists studies that are recruiting volunteers. The link below searches it for Non-Nutritive Sweeteners among studies recruiting now. EBL has no relationship with any listed study and receives no payment for this link.

Search recruiting studies of Non-Nutritive Sweeteners on ClinicalTrials.gov

Dose, form and timing

What to track

Body weight over months.

Safety

Safety evidence, by strength

No safety data. Each caution on this record, sorted by what it rests on.

Documented in human studies
Cautions resting on what randomized trials or large studies found in people.

None recorded.

Suspected from case reports
Harms reported in individual patients or uncontrolled observations, not confirmed by a trial.

None recorded.

Mechanistic only
Cautions reasoned from how it works, with no human harm data behind them.

None recorded.

Population cautions
Groups in whom it has not been studied, so its safety there is unknown.

None recorded.

No safety data

No safety data: EBL has found no trial or report of harm for this record. That is an absence of evidence, not a finding of safety.

Grade history

How this letter has changedLatest: No. 441 · November 2026 · First graded.
Grade history
No. 441 · November 2026 · First graded
Low-calorie sweeteners in place of sugar enters the food section: Grade C

New record in the food section. In randomized trials lasting 4 weeks to 40 months, people given low-calorie sweeteners instead of sugar lost about 1.35 kg more weight, and short trials found lower energy intake. Body weight counts toward a B when trials treat obesity for at least 6 months, which these were not, so the letter is C.PMID 26365102

Every change to a letter on this site is dated and published. The full evidence log →

Sources

How this record was checked
Citations
Every paper cited on this page is matched to its PubMed record on every build.
Retractions
None of these papers is retracted or under a journal expression of concern. PubMed is checked again on every build.
Read against the papers
November 2026. By a language model (AI-assisted reading), not yet reviewed by a clinician.
Outside review
Not yet done. No reviewer outside EBL has checked this record.

What each of these checks can and cannot show: evidence integrity.

The evidence, in fullTwo papers, each linked to its PubMed record.
The evidence

Rogers et al. (Int J Obes, 2016; PMID 26365102): systematic review of animal and human studies; meta-analysis of sustained randomized trials (4 weeks to 40 months, nine comparisons) found low-energy sweeteners in place of sugar reduced body weight by 1.35 kg (95% CI 0.42 to 2.28) and short-term trials found about 94 kcal lower energy intake at a test meal; prospective cohort associations were inconsistent. Li et al. (J Endocrinol Invest, 2025; PMID 40913681): meta-analysis of 19 randomized trials; replacing caloric sugars with non-nutritive sweeteners lowered weight by 0.79 kg (95% CI 0.04 to 1.55), significant in trials under 18 weeks and not in longer trials.

How EBL searched for the trials (1 search)

The search that was run, what it returned, and what was left out and why, so the absence of evidence can be checked as well as its presence.

Searched PubMed in November 2026. 20 records screened, 1 eligible for the graded claim.
Query: ("low-calorie sweetener*"[tiab] OR "non-nutritive sweetener*"[tiab] OR "artificial sweetener*"[tiab]) AND (weight[tiab]) AND (randomized controlled trial[pt] OR meta-analysis[pt])
The 20 most recent of 51 records were screened by title. The 2025 meta-analysis of 19 trials (PMID 40913681) was read and is on the record; a 2025 review within weight-management programs (PMID 40668953) was read and does not change the letter.
PubMed watch: does a new study change the grade? (nothing new)

No new paper matching the search behind this grade has been added to PubMed since November 2026.

Last run November 2026. A letter on EBL moves only after a logged review. A new paper never moves a letter by arriving: it is read, the answer is written here, and any change to the letter is published in the evidence log.

Disclosure

Educational use only · Not medical advice · EBL grades published human evidence and does not recommend treatment. Stopping a prescription is a decision for your physician.

Evidence Based Longevity, Inc. is owner-operated and edited by Arnold Sandlow, D.C., a California-licensed chiropractor. Evidence Based Longevity publishes in English only · Machine translations are not produced or reviewed by EBL for accuracy

© Evidence Based Longevity, Inc. All rights reserved

Medical disclaimer

These statements have not been evaluated by the Food and Drug Administration. Any grade on this page describes the strength of published human trial evidence in the populations studied. It is not a recommendation for any individual and is not medical advice. Starting, stopping or changing any supplement or medication is a decision for your physician.

Grades move when new trials publish. A free monthly email lists every grade EBL moved, with the reason and the trial behind it: the sign-up is on the Evidence Log →

Build 9b19d78, November 2026